A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions.

71 In addition, a post-MI cohort study showed a trend toward increased event rates was observed in individuals with Lp(a) levels of 30–49 and ≥50 mg/dL, compared to those with <30 mg/dL. 75 Another post-PCI cohort demonstrated that high Lp(a) levels (≥30 mg/dL) were significantly associated with increased CV event risks, compared to low Lp(a) levels (<30 mg/dL). 76 Considering the results of both primary and secondary prevention studies, the Korean task force has proposed the following practical 3-tiered classification ( Fig. 3B ): • Normal: <30 mg/dL • Borderline high: 30–49 mg/dL • High: ≥50 mg/dL LP(a) TESTS 1.

also in 53,322 other papers